In this month’s Ophthalmic Drug Delivery issue of ONdrugDelivery magazine, read about how Aptar Pharma is delivering on the growing need for topical preservative-free ophthalmic treatments. Authored by Matthias Birkhoff, Vice-President Business Development at Aptar Pharma, this article gives an overview of the existing technologies available in ophthalmic drug delivery and describes the progress that has been made in topically-applied medications. Birkhoff asserts that more and more topical applications are required to be provided as preservative-free formulations in multi-dose delivery systems, such as Aptar Pharma’s Ophthalmic Squeeze Dispenser (OSD), the only U.S. FDA-reviewed multi-dose eye dispenser. This article also introduces a new market standard for testing microbial integrity in preservative-free formulations, the TSIT 2.0, which has recently been developed by Aptar Pharma.
Read the full article here.